20.5 C
New York
Thursday, June 18, 2026

Tag: institute

newssourceFORcompanyinformationcontent1marketreleases

xCures Achieves Fully Functional IAS Solution

The fully operational Individual Access Services (IAS) solution under TEFCA will deliver on the promise of truly connected healthcare by giving patients and providers...

Regal Rexnord Names Kevin Long EVP & President, Automation & Motion Control (AMC)

Kevin Zaba to Retire as EVP & President, AMC MILWAUKEE, Aug. 8, 2025 /PRNewswire/ -- Regal Rexnord Corporation (NYSE: RRX) today announced it has appointed Kevin...

MBOLD and AURI Launch “Protein Navigator” to Guide Protein Innovators into Minnesota’s Thriving Food and Ag Ecosystem

MINNEAPOLIS and ST. PAUL, Minn., Aug. 08, 2025 (GLOBE NEWSWIRE) -- As global demand for protein continues to rise, Minnesota-based MBOLD (an initiative of the GREATER MSP Partnership) and the Agricultural Utilization Research Institute (AURI) have launched the Protein Navigator, a new service designed to help protein-focused companies explore, enter and grow within Minnesota’s dynamic food and agriculture ecosystem.

Public and Private Sectors Unite to Enhance Vision Care Access for Patients in Need Ahead of SG60

SNEC, Spectacle Hut, and the OneSight EssilorLuxottica Foundation streamline access to specialised eyewear for low vision patients ahead of SG60.

Denison Reports Financial and Operational Results for Q2 2025, Highlighted by Return to Uranium Production at McClean Lake and Provincial Approval of Wheeler River...

TORONTO, Aug. 7, 2025 /PRNewswire/ - Denison Mines Corp. ('Denison' or the 'Company') (TSX: DML) (NYSE American: DNN) today filed its Condensed Consolidated Financial Statements and...

Denison Reports Financial and Operational Results for Q2 2025, Highlighted by Return to Uranium Production at McClean Lake and Provincial Approval of Wheeler River...

TORONTO, Aug. 7, 2025 /CNW/ - Denison Mines Corp. ('Denison' or the 'Company') (TSX: DML) (NYSE American: DNN) today filed its Condensed Consolidated Financial Statements and...

Wheaton Precious Metals Announces Record Revenue and Operating Cash Flow for the Second Quarter of 2025

SECOND QUARTER FINANCIAL RESULTS VANCOUVER, BC, Aug. 7, 2025 /PRNewswire/ - "Wheaton delivered another outstanding quarter, achieving record revenue, adjusted net earnings, and operating cash...

Wheaton Precious Metals Announces Record Revenue and Operating Cash Flow for the Second Quarter of 2025

SECOND QUARTER FINANCIAL RESULTS VANCOUVER, BC, Aug. 7, 2025 /CNW/ - "Wheaton delivered another outstanding quarter, achieving record revenue, adjusted net earnings, and operating cash...

Sandstorm Gold Royalties Reports Record Operating Results in Second Quarter 2025

VANCOUVER, BC, Aug. 7, 2025 /PRNewswire/ - Sandstorm Gold Ltd. ("Sandstorm Gold Royalties", "Sandstorm" or the "Company") (NYSE: SAND) (TSX: SSL) has released its...

Sandstorm Gold Royalties Reports Record Operating Results in Second Quarter 2025

VANCOUVER, BC, Aug. 7, 2025 /CNW/ - Sandstorm Gold Ltd. ("Sandstorm Gold Royalties", "Sandstorm" or the "Company") (NYSE: SAND) (TSX: SSL) has released its...

Don Hertzfeldt’s Animation Mixtape Drops First Teaser and Announces Initial Wave of Opening Dates

Feature-length collection of surreal and sublime animated shorts will debut in first in more than 15 major cities – teaser created by Hertzfeldt features...

BDC Laboratories Partners with Newly Launched Dilawri Cardiovascular Institute to Advance Clinically Relevant Cardiovascular Device Testing

Strategic collaboration supports cutting-edge translational research, combining regulatory-grade bench testing with clinical insight to improve outcomes for patients. WHEAT RIDGE, Colo. and VANCOUVER, BC, Aug....

BDC Laboratories Partners with Newly Launched Dilawri Cardiovascular Institute to Advance Clinically Relevant Cardiovascular Device Testing

Strategic collaboration supports cutting-edge translational research, combining regulatory-grade bench testing with clinical insight to improve outcomes for patients. WHEAT RIDGE, Colo. and VANCOUVER, BC, Aug....

US NCI Sponsors Senhwa Biosciences’ Second Program-IND Submitted for Clinical Trial Targeting MYC-Aberrant Lymphoma

TAIPEI and SAN DIEGO, Aug. 7, 2025 /PRNewswire/ -- Senhwa Biosciences, Inc. (TPEx: 6492), a new drug development company focusing on first-in-class therapeutics for...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsInstitute

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers